Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cellebrite Di Ltd (NQ: CLBT )

19.72 -0.46 (-2.28%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cellebrite Di Ltd

< Previous 1 2 Next >
Mailbag With Motley Fool Co-Founder Tom Gardner
Today's show is a cut of our members-only podcast, "Stock Advisor Roundtable." 
Via The Motley Fool
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
Via Benzinga
CLBT Stock Earnings: Cellebrite DI Beats EPS, Beats Revenue for Q2 2024
CLBT stock results show that Cellebrite DI beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Will The Nasdaq 100's Relief Rally Hold Or Is A Sharp Decline Inevitable?
Find out how might the rotation of funds into small-cap stocks and the Dow Jones affect the Nasdaq 100. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Earnings Scheduled For February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
Via Benzinga
Cellebrite DI: Q3 Earnings Insights
Via Benzinga
What 4 Analyst Ratings Have To Say About Cellebrite DI
Via Benzinga
Expert Ratings for Cellebrite DI
Via Benzinga
FBI Reportedly Used Israel-Based Security Firm's Unreleased Technology To Crack Trump Shooter's Phone
Despite having a license for Cellebrite's software, the FBI's Pittsburgh bureau was unable to bypass the passcode on Crooks' newer Samsung model phone, which runs on Android's operating system. 
Via Benzinga
Topics Government
Exposures Criminal Legal Political
Why Software Company Cellebrite Shares Are Up Today
Cellebrite DI reported strong Q1 FY24 results with revenue up 26% YoY, ARR at $331.8 million, and EPS beating consensus. Outlook remains positive with expected revenue of $90M-$94M in Q2 and... 
Via Benzinga
CLBT Stock Earnings: Cellebrite DI Beats EPS, Beats Revenue for Q1 2024
CLBT stock results show that Cellebrite DI beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Preview: Cellebrite DI's Earnings
Via Benzinga
Recap: Cellebrite DI Q1 Earnings
Via Benzinga
The 7 Best Stocks Under $10 to Buy in May
While quality matters in the market, these best stocks under $10 to buy gives you some potential diamonds in the rough. 
Via InvestorPlace
Earnings Preview For Cellebrite DI
Via Benzinga
Expert Ratings for Cellebrite DI
  Analysts have provided the following ratings for Cellebrite DI (NASDAQ:CLBT) within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Major Compression Regimes In Multiple Markets…
In this week’s Dirty Dozen we cover more recession signals, bullish price action in the main markets, a big set up in the US dollar, a major compression regime in bonds, and more… 
Via Talk Markets
7 Tech Stocks to Buy for the Next Decade
While jitters abound, intrepid investors may target these compelling innovators. 
Via InvestorPlace
Jabil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Tuesday
Raymond James raised the price target for Jabil Inc. (NYSE: JBL) from $84 to $100. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares fell 0.7% to close at $81.35 on... 
Via Benzinga
7 Tech Stocks to Snatch Out of the Bargain Bin
Although the innovation space provides several compelling opportunities, you don’t have to pay full price with these tech stock bargains. 
Via InvestorPlace
Earnings Scheduled For November 17, 2022
Companies Reporting Before The Bell • Jumia Technologies (NYSE:JMIA) is expected to report quarterly loss at $0.76 per share on revenue of $57.32 million. 
Via Benzinga
Overview Of Value Stocks In The Technology Sector
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time for another deep dive into the biggest pre-market stock movers for Friday and the news that has these shares moving this morning. 
Via InvestorPlace
Overview Of Value Stocks In The Technology Sector
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
5 Value Stocks To Watch In The Technology Sector
What are Value Stocks? 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
  
Via Benzinga
Where Cellebrite DI Stands With Analysts
Cellebrite DI (NASDAQ:CLBT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises 2%; EIA Reports Unexpected Rise In Crude Inventories
US stocks traded lower midway through trading on Wednesday ahead of the release of Fed minutes. 
Via Benzinga
56 Biggest Movers From Yesterday
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.